Apellis Pharmaceuticals Inc. News
Cramer's Mad Money Recap 10/6: Dow, General Motors
Jim Cramer says it's hard to explain why stocks opened lower, but he thinks investors should have some conviction and look for buying opportunities.
5 Top Stock Gainers for Monday: Discovery, Apellis Pharma
Apellis Pharmaceuticals, Harley-Davidson, Dillard's, Children's Place and Harmony Gold are five top gainers for Monday.
Apellis Jumps on Blood Disease Treatment Approval
Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.
Editas Medicine Falls as Goldman Sachs Initiates the Stock at Sell
Editas is initiated with a sell rating and $20 price target at Goldman Sachs.
Resilient Bull: Cramer's 'Mad Money' Recap (Wednesday 1/8/20)
Jim Cramer says this market environment is a strange merger of resilience, complacency and hubris. He explains how this feeds a stock rally.
Costco May Have a Huge Workers Problem
Workers demand for their needs to be met.
Real Estate Titan Zillow Sees Tough Times Ahead in Housing
The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.
Meta (Facebook) Looks to Take on TikTok Next
Facebook and Instagram's parent company has a plan to take over a new segment.